Bicocca Open Archive

Logo unimib boa
MAGISTRONI, VERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.150
EU - Europa 3.202
AS - Asia 3.072
SA - Sud America 435
Continente sconosciuto - Info sul continente non disponibili 292
AF - Africa 79
OC - Oceania 11
Totale 14.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.764
SG - Singapore 1.059
CN - Cina 728
DE - Germania 612
IT - Italia 569
VN - Vietnam 427
SE - Svezia 404
RU - Federazione Russa 399
IE - Irlanda 356
HK - Hong Kong 350
CA - Canada 322
BR - Brasile 312
UA - Ucraina 232
GB - Regno Unito 201
FR - Francia 124
IN - India 116
FI - Finlandia 89
TR - Turchia 59
BD - Bangladesh 58
KR - Corea 48
AR - Argentina 43
IQ - Iraq 38
PL - Polonia 36
ID - Indonesia 35
BE - Belgio 34
NL - Olanda 34
ZA - Sudafrica 34
MX - Messico 30
DK - Danimarca 28
ES - Italia 27
JP - Giappone 24
CO - Colombia 23
SA - Arabia Saudita 21
PK - Pakistan 17
VE - Venezuela 15
EC - Ecuador 14
NP - Nepal 12
PH - Filippine 12
AU - Australia 11
AT - Austria 10
LT - Lituania 10
UZ - Uzbekistan 10
BG - Bulgaria 9
CL - Cile 9
EU - Europa 9
JM - Giamaica 8
JO - Giordania 8
MA - Marocco 8
MY - Malesia 8
PE - Perù 8
CH - Svizzera 7
EG - Egitto 7
KE - Kenya 7
CZ - Repubblica Ceca 6
IR - Iran 6
AZ - Azerbaigian 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HN - Honduras 5
IL - Israele 5
TN - Tunisia 5
PY - Paraguay 4
RO - Romania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
HU - Ungheria 2
LY - Libia 2
MG - Madagascar 2
NI - Nicaragua 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
MT - Malta 1
PA - Panama 1
PR - Porto Rico 1
Totale 13.955
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.035
Ashburn 670
Singapore 620
Woodbridge 446
San Jose 368
Chandler 354
Dublin 348
Hong Kong 342
Fairfield 332
Frankfurt am Main 274
Houston 270
Milan 237
Jacksonville 224
Toronto 218
Wilmington 209
Dearborn 205
New York 169
Seattle 131
Los Angeles 127
Santa Clara 122
Ho Chi Minh City 120
Beijing 119
Cambridge 107
Dallas 97
Chicago 94
Göttingen 91
Princeton 91
Hanoi 89
Council Bluffs 88
Shanghai 81
The Dalles 73
Nanjing 61
Boardman 55
Hefei 49
Lauterbourg 43
Altamura 41
Munich 41
Seoul 40
São Paulo 40
Lachine 38
Moscow 36
Lawrence 35
Brussels 34
Fürstenwalde 32
Helsinki 30
Buffalo 29
Rome 29
Warsaw 28
Dong Ket 27
San Diego 26
Fremont 25
London 25
Shenyang 24
Orem 23
Atlanta 22
Da Nang 21
Jakarta 21
Montreal 21
Tianjin 20
Tokyo 20
Andover 18
Johannesburg 18
Guangzhou 17
Washington 17
Changsha 16
Chennai 16
Ottawa 16
Baghdad 15
Nuremberg 15
Brooklyn 14
Huizen 14
Philadelphia 14
Columbus 13
Haiphong 13
Hebei 13
Jinan 13
Manchester 13
Nanchang 13
San Francisco 13
Boston 12
Denver 12
Jiaxing 12
Stockholm 12
Turku 12
Mumbai 11
Pune 11
Verona 11
Can Tho 10
Kunming 10
Lissone 10
Phoenix 10
Ankara 9
Falls Church 9
Mexico City 9
Romola 9
Salt Lake City 9
Tashkent 9
Amman 8
Amsterdam 8
Belo Horizonte 8
Totale 9.179
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 627
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 477
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 474
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 462
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 430
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 423
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 420
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 404
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 396
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 388
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 377
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 355
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 340
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 338
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al 337
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 337
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 330
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 330
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 330
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex 325
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 319
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 319
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 314
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 297
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 286
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 281
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 280
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 272
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 270
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2 269
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 266
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 260
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 255
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 234
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 233
BIM promoter is epigenetically silenced in malignant lymphoid cells, leading to downregulation of BIM expression and protection from apoptosis 231
The novel PIM1 inhibitor NMS-P645 reverses PIM1-Dependent effects on TMPRSS2/ERG positive Prostate cancer cells and shows anti-proliferative activity in combination with PI3K inhibition 219
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 211
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents 211
Mechanisms of Bim epigenetic silencing in anaplastic large cell lymphoma 208
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 194
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 192
Reactivation of an Epigenetic Silenced Tumor Suppressor Gene BIM in Anaplastic Large Cell Lymphoma Leads to massive Apoptosis 187
Role of TMPRSS2/ERG in cellular transformation 179
Reversal of glucocorticoid resistance in human lymphoid malignancies with histone deacetylase inhibitors 177
Epigenetic changes at the bim locus associated with glucocorticoid resistance in human lymphoid malignancies 177
Totale 14.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022573 0 0 103 45 47 62 38 32 32 61 47 106
2022/20231.298 157 426 113 127 94 181 15 64 87 5 19 10
2023/2024930 23 32 33 47 126 285 205 15 59 16 4 85
2024/20251.716 112 190 108 102 156 58 102 31 124 314 156 263
2025/20264.652 503 222 359 564 568 218 671 173 362 452 307 253
2026/2027388 105 183 100 0 0 0 0 0 0 0 0 0
Totale 14.241